Bullish vs. Bearish (1 opinions)
Social Sentiment 0.85
ALXN Forecast and Technical Stock Analysis
Buy candidate since 2019-12-12 Loss -1.82% PDF
Alexion Pharmaceuticals fell by -1.82% in the last day ( Friday, 13th Dec 2019 ) from $112.47 to $110.42 During the day the stock fluctuated 3.71% from a day low at $109.72 to a day high of $113.79. The price has fallen in 6 of the last 10 days and is down by -3.09% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -0.24 million shares and in total 1.50 million shares bought and sold for approximately $166.07 million.
- 30 day high of the ALXN stock price was $116.59 and low was $104.52.
- 90 day high was $116.59 and low was $94.59.
- 52 week high for Alexion Pharmaceuticals - $141.86 and low - $92.56.
Alexion Pharmaceuticals lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 13.81% during the next 3 months and, with 90% probability hold a price between $120.04 and $136.52 at the end of this period.
Alexion Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $111.05. On a fall, the stock will find some support from the long-term average at approximately $109.87. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday December 12, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 49 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Alexion Pharmaceuticals finds support from accumulated volume at $108.53.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $4.07 (3.71%) between high and low. For the last week, the stock has had daily average volatility of 3.54%.
Our recommended stop-loss: $104.89 (-5.01%) (This stock has low daily movements and this gives low risk. There is a sell signal from pivot top found 1 day(s) ago.)
3.54 %Average volatility
Very Low Low Medium High Very High
|ALXN $110.42 ($-2.05 -1.82%)|
ALXN is down $2.05 today, but where's it headed in 2020?
|Zacks Investment Research is releasing its prediction for ALXN based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ALXN analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!